C&EN’s Weekly Newsletter has evolved. Meet C&EN Elements, redesigned to deliver the essential developments in chemistry across research, industry, and policy: https://t.co/i3DTm71mUm
Listen to our award-winning podcast Inflection Point and other offerings from Stereo Chemistry on your podcast listening app of choice, or download single episodes right from our website:
https://t.co/2hevNAjPJW
Chemical & Engineering News will continue to be the most comprehensive and authoritative source of news about chemistry and related fields, covering research, business, and policy.
Sign-up for the C&EN Elements newsletter to get a weekly update the most important developments in chemistry to give you an edge in your industry:
https://t.co/fy6r02X5dN
Researchers have reported that they've combined two approaches to heat up immunity against solid tumors. The result is one molecule that can be both a checkpoint degrader and a cancer vaccine. https://t.co/d6JrsKhbG7
Sensory overload: encapsulated fragrances and flavors can infuse gifts with the essence of fresh pastries or even bacon-wrapped sausage. https://t.co/XoGOigazhN
Platinum has long powered hydrogenation reactions across the chemical industry. But its cost and limited supply have pushed chemists to search for cheaper, Earth-abundant alternatives. https://t.co/9btCofkn4b
Built for quick scanning so you can stay informed in just a few minutes. Sign up to get the essential chemistry briefing delivered to your inbox: https://t.co/i3DTm71mUm
Feedback? We’d love to hear from you: [email protected]
C&EN’s Weekly Newsletter has evolved. Meet C&EN Elements, redesigned to deliver the essential developments in chemistry across research, industry, and policy: https://t.co/i3DTm71mUm
The first day of San Francisco’s J.P. Morgan Healthcare Conference, usually punctuated by major announcements of mergers and acquisitions (M&A), and high-dollar licensing deals, had no such news to kick off 2026. https://t.co/I5p23gCjcq
This week in the C&EN Magazine: A look back at 15 of ACS’s most consequential presidents + The headlines we expect in 2026 + C&EN’s World Chemical Outlook for 2026. Read more: https://t.co/QWQLUYQjri
Aurora Therapeutics has emerged from stealth with $16 million in funding from Menlo Ventures to expand the potential of gene editing to treat rare diseases. Its initial program focuses on phenylketonuria, a genetic metabolic disorder. https://t.co/vRBdg0iKBH
This array of bolts looks heavy duty, but the impressive part is happening below it. Andrea Klenotiz and other scientists at Lectrolyst were preparing this electrochemical reactor—the stack of plates under the rods—for a demonstration: https://t.co/8iMWbnXvuG
#CENChemPics
Jan. 13 Business Watch: Plants close in Brazil and the UK; Lilly to pay $1.2 billion for Ventyx
Here’s what we’re watching in chemistry business news this week: https://t.co/e3eeMvgUYj
Chemists have constructed the complex natural products secalosides A and B from simple chemical building blocks for the first time. https://t.co/HoOzz1LWAu
Who inspires you? Nominate an early-career chemist for the 2026 Talented 12 at https://t.co/Hcks50BJuz
Deadline to submit a nomination: January 20, 2026.
#CENT12#Biochemistry#DrugDiscovery#Chemistry
As US teachers discover more and more legacy chemicals in schools, funding for cleanup is hard to find. Educators, nonprofits, and local governments are stepping in to help. https://t.co/YxKhGXUOhL
Nominate an innovative early-career chemist for the Talented 12 Class of 2026. Celebrate bold ideas and global impact in chemistry. Deadline to submit is January 20. Nominate someone now: https://t.co/Hcks50BJuz
#CENT12
The unique location of Xizang University in Lhasa, Tibet, China (seen here from afar) allowed researchers to disentangle the health effects of ozone-derived carbonyls from ozone itself. https://t.co/LECYT4Z9mf